CIK 0001725430 · Non-accelerated filer<br>Smaller reporting company
INTELLIGENT BIO SOLUTIONS INC.
Sign in to watch- Ticker
- INBS
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 821512711
- Phone
- 646-790-5756
- Business address
- 135 W 41ST ST,, FLOOR 5, NEW YORK, NY, 10036
- Former names
- GBS Inc., Glucose Biosensor Systems (Greater China) Holdings, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-18 | Boyages Steven Constantine Director | Grant or award | +5,000 | 5,031 | ||
| 2026-03-18 | Fraser Nicola Marion Director | Grant or award | +5,000 | 5,000 | ||
| 2026-03-18 | Sakiris Spiro Kevin Chief Financial Officer | Grant or award | +9,150 | 12,631 | ||
| 2026-03-18 | Sakiris Spiro Kevin Chief Financial Officer | Grant or award | +21,350 | 33,981 | ||
| 2026-03-18 | Isenberg Jason Director | Grant or award | +5,000 | 5,000 | ||
| 2026-03-18 | Hurd Jonathan Scott Director | Grant or award | +5,000 | 5,006 | ||
| 2026-03-18 | Simeonidis Harry Chief Executive Officer | Grant or award | +9,150 | 13,190 | ||
| 2026-03-18 | Simeonidis Harry Chief Executive Officer | Grant or award | +21,350 | 34,540 | ||
| 2024-09-25 | Sakiris Spiro Kevin Chief Financial Officer | Grant or award | +34,500 | 34,815 | ||
| 2024-09-25 | Simeonidis Harry Chief Executive Officer | Grant or award | +40,000 | 40,408 | ||
| 2024-09-25 | Sakiris Spiro Kevin Chief Financial Officer | Grant or award | +34,500 | 34,815 | ||
| 2024-03-20 | Sakiris Spiro Kevin Chief Financial Officer | Option exercise | +9,394 | 19,180 | ||
| 2024-03-20 | Sakiris Spiro Kevin Chief Financial Officer | Option exercise · Common Stock Warrants (Series F) | −9,394 | 0 | ||
| 2023-10-04 | TOWERS CHRISTOPHER Director | Purchase | +9,090 | 9,880 | ||
| 2023-10-04 | TOWERS CHRISTOPHER Director | Purchase · Common Stock Warrants (Series E) | +9,090 | 9,090 | ||
| 2023-10-04 | TOWERS CHRISTOPHER Director | Purchase · Common Stock Warrants (Series F) | +9,090 | 9,090 | ||
| 2023-10-04 | Sakiris Spiro Kevin Chief Financial Officer | Purchase | +112,727 | 117,427 | ||
| 2023-10-04 | Sakiris Spiro Kevin Chief Financial Officer | Purchase · Common Stock Warrants (Series E) | +112,727 | 112,727 | ||
| 2023-10-04 | Sakiris Spiro Kevin Chief Financial Officer | Purchase · Common Stock Warrants (Series F) | +112,727 | 112,727 | ||
| 2023-09-01 | Simeonidis Harry CEO | Purchase | +50 | $1.85 | $93 | 4,180 |
Page 1 of 4 · 77 trades